Boxer Boxer AL AL Qureshi Qureshi I I Ahlijanian Ahlijanian M M Grundman Grundman M M Golbe Golbe LI LI Litvan Litvan I I Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial Lancet Neurol Lancet Neurol 2019 2019 18 18 6 6 P549 P549 P558 P558 10.1016/S1474-4422(19)30139-5 10.1016/S1474-4422(19)30139-5. This evidence concerns the gene MAPT and Classical progressive supranuclear palsy.